应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BRTX BioRestorative Therapies, Inc.
已收盘 02-27 16:00:00 EST
0.2284
-0.0030
-1.30%
盘后
0.2193
-0.0091
-3.98%
19:59 EST
最高
0.2284
最低
0.2113
成交量
396.05万
今开
0.2191
昨收
0.2314
日振幅
7.39%
总市值
529.02万
流通市值
474.61万
总股本
2,316万
成交额
86.62万
换手率
19.06%
流通股本
2,078万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
BioRestorative Therapies, Inc.扩大Thermostem®全球保护范围,该细胞疗法或成GLP-1药物更长效、更安全的替代方案
美股速递 · 02-24
BioRestorative Therapies, Inc.扩大Thermostem®全球保护范围,该细胞疗法或成GLP-1药物更长效、更安全的替代方案
Biorestorative Therapies, Inc.盘中异动 股价大跌5.35%
市场透视 · 02-23
Biorestorative Therapies, Inc.盘中异动 股价大跌5.35%
Biorestorative Therapies, Inc.盘中异动 急速下跌5.04%
市场透视 · 02-19
Biorestorative Therapies, Inc.盘中异动 急速下跌5.04%
BioRestorative宣布与FDA B类会议取得积极成果
投资观察 · 02-11
BioRestorative宣布与FDA B类会议取得积极成果
BioRestorative Therapies公司预计三期临床试验新药申请将于2026年下半年提交
美股速递 · 02-11
BioRestorative Therapies公司预计三期临床试验新药申请将于2026年下半年提交
Biorestorative Therapies, Inc.股价重挫18.29% 市值跌138.62万美元
市场透视 · 02-10
Biorestorative Therapies, Inc.股价重挫18.29% 市值跌138.62万美元
BioRestorative Therapies, Inc. 完成慢性腰椎间盘疾病创新疗法Brtx-100的里程碑式二期临床试验患者入组
美股速递 · 02-10
BioRestorative Therapies, Inc. 完成慢性腰椎间盘疾病创新疗法Brtx-100的里程碑式二期临床试验患者入组
Biorestorative Therapies, Inc.盘中异动 早盘股价大涨5.34%报1.16美元
市场透视 · 02-04
Biorestorative Therapies, Inc.盘中异动 早盘股价大涨5.34%报1.16美元
Biorestorative Therapies, Inc.盘中异动 急速下挫5.86%
市场透视 · 2025-11-26
Biorestorative Therapies, Inc.盘中异动 急速下挫5.86%
BioRestorative获得与FDA的B类会议以讨论BRTX-100在慢性腰椎间盘疾病中的加速BLA审批路径
美股速递 · 2025-11-17
BioRestorative获得与FDA的B类会议以讨论BRTX-100在慢性腰椎间盘疾病中的加速BLA审批路径
Biorestorative Therapies, Inc.盘中异动 大幅下跌5.71%
市场透视 · 2025-11-07
Biorestorative Therapies, Inc.盘中异动 大幅下跌5.71%
Biorestorative Therapies, Inc.盘中异动 临近午盘急速下跌5.45%报1.56美元
市场透视 · 2025-10-29
Biorestorative Therapies, Inc.盘中异动 临近午盘急速下跌5.45%报1.56美元
BioRestorative获得日本专利批准通知 – 拓展对潜在细胞基替代品的保护,目标为数十亿美元的GLP-1药物市场
美股速递 · 2025-10-27
BioRestorative获得日本专利批准通知 – 拓展对潜在细胞基替代品的保护,目标为数十亿美元的GLP-1药物市场
BioRestorative加强商业领导力,任命Crystal Romano为全球商业运营负责人以加速细胞产品组合的增长
美股速递 · 2025-10-22
BioRestorative加强商业领导力,任命Crystal Romano为全球商业运营负责人以加速细胞产品组合的增长
Biorestorative Therapies, Inc.盘中异动 股价大跌6.90%报1.35美元
市场透视 · 2025-10-01
Biorestorative Therapies, Inc.盘中异动 股价大跌6.90%报1.35美元
Biorestorative Therapies, Inc.盘中异动 大幅上涨5.59%报1.51美元
市场透视 · 2025-03-06
Biorestorative Therapies, Inc.盘中异动 大幅上涨5.59%报1.51美元
Biorestorative Therapies, Inc.盘中异动 早盘股价大跌7.28%
市场透视 · 2025-03-04
Biorestorative Therapies, Inc.盘中异动 早盘股价大跌7.28%
Biorestorative Therapies, Inc.盘中异动 早盘股价大跌5.56%报1.53美元
市场透视 · 2025-02-28
Biorestorative Therapies, Inc.盘中异动 早盘股价大跌5.56%报1.53美元
Biorestorative Therapies, Inc.盘中异动 早盘股价大跌9.69%报1.73美元
市场透视 · 2025-02-27
Biorestorative Therapies, Inc.盘中异动 早盘股价大跌9.69%报1.73美元
Biorestorative Therapies, Inc.盘中异动涨4.37% 换手率达23.45%
市场透视 · 2025-02-25
Biorestorative Therapies, Inc.盘中异动涨4.37% 换手率达23.45%
加载更多
公司概况
公司名称:
BioRestorative Therapies, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Biorestorative医疗公司于1997年6月13日在内华达州注册成立。该公司目前正在开展Disc/Spine计划,初步研究治疗产品被称为BRTX-100。2022年3月,在Disc/Spine Program中发布了一项美国专利。该公司向美国食品药品监督管理局(FDA)提交了一份IND申请,以获得授权开始一项2期临床试验,调查使用BRTX-100治疗退行性椎间盘疾病引起的慢性下背痛。该公司已获得FDA的此类授权,并已开始此类临床试验。
发行价格:
--
{"stockData":{"symbol":"BRTX","market":"US","secType":"STK","nameCN":"BioRestorative Therapies, Inc.","latestPrice":0.2284,"timestamp":1772226000000,"preClose":0.2314,"halted":0,"volume":3960492,"hourTrading":{"tag":"盘后","latestPrice":0.2193,"preClose":0.2284,"latestTime":"19:59 EST","volume":343656,"amount":74275.39427,"timestamp":1772240360829,"change":-0.0091,"changeRate":-0.039842,"amplitude":0.07609},"delay":0,"changeRate":-0.012964563526361291,"floatShares":20779899,"shares":23162000,"eps":-1.475385,"marketStatus":"已收盘","change":-0.003,"latestTime":"02-27 16:00:00 EST","open":0.2191,"high":0.2284,"low":0.2113,"amount":866191.44275568,"amplitude":0.073898,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.475385,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1772442000000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":0.2314,"preHourTrading":{"tag":"盘前","latestPrice":0.219,"preClose":0.2314,"latestTime":"09:28 EST","volume":266209,"amount":58741.81370659,"timestamp":1772202536219,"change":-0.0124,"changeRate":-0.053587,"amplitude":0.075627},"postHourTrading":{"tag":"盘后","latestPrice":0.2193,"preClose":0.2284,"latestTime":"19:59 EST","volume":343656,"amount":74275.39427,"timestamp":1772240360829,"change":-0.0091,"changeRate":-0.039842,"amplitude":0.07609},"volumeRatio":0.079143},"requestUrl":"/m/hq/s/BRTX","defaultTab":"news","newsList":[{"id":"1102433433","title":"BioRestorative Therapies, Inc.扩大Thermostem®全球保护范围,该细胞疗法或成GLP-1药物更长效、更安全的替代方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1102433433","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102433433?lang=zh_cn&edition=full","pubTime":"2026-02-24 21:35","pubTimestamp":1771940125,"startTime":"0","endTime":"0","summary":"BioRestorative Therapies, Inc.正在强化其创新疗法Thermostem®的全球知识产权保护布局。该细胞疗法有望成为GLP-1类药物的一种新型替代方案,其特点在于可能具备更持久的疗效和更高的安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BRTX"],"gpt_icon":0},{"id":"2613750695","title":"Biorestorative Therapies, Inc.盘中异动 股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613750695","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613750695?lang=zh_cn&edition=full","pubTime":"2026-02-23 22:31","pubTimestamp":1771857080,"startTime":"0","endTime":"0","summary":"北京时间2026年02月23日22时31分,Biorestorative Therapies, Inc.股票出现波动,股价大幅下跌5.35%。Biorestorative Therapies, Inc.股票所在的生物技术行业中,整体跌幅为0.21%。其相关个股中,Arcellx, Inc.、Vanda Pharmaceuticals Inc.、传奇生物涨幅较大,Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.、Fortress Biotech, Inc.较为活跃,换手率分别为174.79%、31.25%、25.43%,振幅较大的相关个股有Cardio Diagnostics Holdings Inc.、Camp4 Therapeutics Corporation、Aspire Biopharma Holdings, Inc.,振幅分别为11.46%、9.68%、9.50%。Biorestorative Therapies, Inc.公司简介:BioRestorative Therapies Inc是一家总部位于美国的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223223120a71631bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223223120a71631bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BRTX","BK4139"],"gpt_icon":0},{"id":"2612236552","title":"Biorestorative Therapies, Inc.盘中异动 急速下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612236552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612236552?lang=zh_cn&edition=full","pubTime":"2026-02-19 23:24","pubTimestamp":1771514664,"startTime":"0","endTime":"0","summary":"北京时间2026年02月19日23时24分,Biorestorative Therapies, Inc.股票出现异动,股价快速下挫5.04%。Biorestorative Therapies, Inc.股票所在的生物技术行业中,整体跌幅为0.88%。其相关个股中,Moolec Science Sa C/Wts 30/01/2028、Cingulate Inc C/Wts 10/12/2026 、Moolec Science Sa涨幅较大,Enveric Biosciences, Inc.、Pmgc Holdings Inc.、Theriva Biologics, Inc.较为活跃,换手率分别为1145.19%、704.43%、649.00%,振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Moolec Science Sa、Theriva Biologics, Inc.,振幅分别为247.75%、51.67%、23.39%。Biorestorative Therapies, Inc.公司简介:BioRestorative Therapies Inc是一家总部位于美国的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021923242595417905&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021923242595417905&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BRTX","BK4139"],"gpt_icon":0},{"id":"1106029431","title":"BioRestorative宣布与FDA B类会议取得积极成果","url":"https://stock-news.laohu8.com/highlight/detail?id=1106029431","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106029431?lang=zh_cn&edition=full","pubTime":"2026-02-11 20:56","pubTimestamp":1770814603,"startTime":"0","endTime":"0","summary":"BioRestorative Therapies Inc 公布其与美国食品药品监督管理局(FDA)举行的B类会议结果积极。\n该公司目前预期将于2026年下半年提交三期临床试验的新药研究申请。\n","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BRTX"],"gpt_icon":0},{"id":"1180857056","title":"BioRestorative Therapies公司预计三期临床试验新药申请将于2026年下半年提交","url":"https://stock-news.laohu8.com/highlight/detail?id=1180857056","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180857056?lang=zh_cn&edition=full","pubTime":"2026-02-11 20:31","pubTimestamp":1770813070,"startTime":"0","endTime":"0","summary":"BioRestorative Therapies公司近日更新了其核心研发管线的时间表。该公司目前预期,其备受关注的三期临床试验的新药研究申请(IND),计划在2026年下半年正式提交。这一进展标志着其在研疗法向商业化迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BRTX"],"gpt_icon":0},{"id":"2610672488","title":"Biorestorative Therapies, Inc.股价重挫18.29% 市值跌138.62万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610672488","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610672488?lang=zh_cn&edition=full","pubTime":"2026-02-10 22:32","pubTimestamp":1770733936,"startTime":"0","endTime":"0","summary":"北京时间2026年02月10日22时32分,Biorestorative Therapies, Inc.股票出现异动,股价大幅下挫18.29%。截至发稿,该股报0.854美元/股,成交量2.2527万股,换手率0.25%,振幅4.25%。Biorestorative Therapies, Inc.股票所在的生物技术行业中,整体跌幅为0.02%。其相关个股中,Quince Therapeutics, Inc.、Evommune, Inc.、Abpro Holdings, Inc涨幅较大,Abpro Holdings, Inc、Phio Pharmaceuticals Corp.、Quince Therapeutics, Inc.较为活跃,换手率分别为982.33%、620.36%、424.96%,振幅较大的相关个股有Quince Therapeutics, Inc.、Abpro Holdings, Inc、Tectonic Therapeutic, Inc.,振幅分别为21.31%、15.79%、10.43%。Biorestorative Therapies, Inc.公司简介:BioRestorative Therapies Inc是一家总部位于美国的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210223216a6eaf7f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210223216a6eaf7f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BRTX"],"gpt_icon":0},{"id":"1189170413","title":"BioRestorative Therapies, Inc. 完成慢性腰椎间盘疾病创新疗法Brtx-100的里程碑式二期临床试验患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1189170413","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189170413?lang=zh_cn&edition=full","pubTime":"2026-02-10 21:03","pubTimestamp":1770728625,"startTime":"0","endTime":"0","summary":"BioRestorative Therapies, Inc. 已成功完成其针对慢性腰椎间盘疾病的候选疗法Brtx-100在二期临床试验中的患者招募工作。这一进展标志着该疗法在临床开发道路上迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BRTX"],"gpt_icon":0},{"id":"2609377083","title":"Biorestorative Therapies, Inc.盘中异动 早盘股价大涨5.34%报1.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609377083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609377083?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:46","pubTimestamp":1770216400,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日22时46分,Biorestorative Therapies, Inc.股票出现波动,股价急速上涨5.34%。Biorestorative Therapies, Inc.股票所在的生物技术行业中,整体涨幅为0.38%。其相关个股中,Celularity Inc C/Wts 16/07/2026 、Liminatus Pharma, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Biodexa Pharmaceuticals Plc、Gri Bio, Inc.、Evogene Ltd.较为活跃,换手率分别为363.03%、189.93%、102.47%,振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Liminatus Pharma, Inc.、Briacell Therapeutics Corp C/Wts ,振幅分别为61.25%、31.77%、22.69%。Biorestorative Therapies, Inc.公司简介:BioRestorative Therapies Inc是一家总部位于美国的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020422464097a4e083&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020422464097a4e083&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BRTX"],"gpt_icon":0},{"id":"2586621100","title":"Biorestorative Therapies, Inc.盘中异动 急速下挫5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586621100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586621100?lang=zh_cn&edition=full","pubTime":"2025-11-26 23:12","pubTimestamp":1764169954,"startTime":"0","endTime":"0","summary":"北京时间2025年11月26日23时12分,Biorestorative Therapies, Inc.股票出现波动,股价大幅下跌5.86%。Biorestorative Therapies, Inc.股票所在的生物技术行业中,整体涨幅为0.42%。其相关个股中,Pasithea Therapeutics Corp C/Wts 12/08/2026 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Scisparc Ltd.涨幅较大,Scisparc Ltd.、Kala Bio, Inc.、Clearmind Medicine Inc.较为活跃,换手率分别为2446.89%、179.84%、55.88%,振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Quantum Biopharma Ltd.,振幅分别为272.65%、88.63%、28.61%。Biorestorative Therapies, Inc.公司简介:BioRestorative Therapies Inc是一家总部位于美国的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126231235951be4d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126231235951be4d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BRTX"],"gpt_icon":0},{"id":"1130577203","title":"BioRestorative获得与FDA的B类会议以讨论BRTX-100在慢性腰椎间盘疾病中的加速BLA审批路径","url":"https://stock-news.laohu8.com/highlight/detail?id=1130577203","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130577203?lang=zh_cn&edition=full","pubTime":"2025-11-17 20:01","pubTimestamp":1763380891,"startTime":"0","endTime":"0","summary":"BioRestorative获得与FDA的B类会议,以讨论BRTX-100在慢性腰椎间盘疾病中的加速生物制品许可申请(BLA)审批路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BRTX"],"gpt_icon":0},{"id":"2581831025","title":"Biorestorative Therapies, Inc.盘中异动 大幅下跌5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581831025","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581831025?lang=zh_cn&edition=full","pubTime":"2025-11-07 22:48","pubTimestamp":1762526931,"startTime":"0","endTime":"0","summary":"北京时间2025年11月07日22时48分,Biorestorative Therapies, Inc.股票出现异动,股价大幅下挫5.71%。截至发稿,该股报1.32美元/股,成交量3160股,换手率0.04%,振幅3.38%。Biorestorative Therapies, Inc.股票所在的生物技术行业中,整体跌幅为0.54%。其相关个股中,Surrozen Inc C/Wts 01/08/2031 、Tharimmune, Inc.、Evommune, Inc.涨幅较大,Metavia Inc.、Phio Pharmaceuticals Corp.、Tharimmune, Inc.较为活跃,换手率分别为114.98%、20.13%、18.54%,振幅较大的相关个股有Tharimmune, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Aspire Biopharma Holdings, Inc.,振幅分别为37.11%、33.73%、21.51%。Biorestorative Therapies, Inc.公司简介:BioRestorative Therapies Inc是一家总部位于美国的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107224851a6e903d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107224851a6e903d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BRTX","BK4139"],"gpt_icon":0},{"id":"2579168096","title":"Biorestorative Therapies, Inc.盘中异动 临近午盘急速下跌5.45%报1.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579168096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579168096?lang=zh_cn&edition=full","pubTime":"2025-10-29 23:48","pubTimestamp":1761752932,"startTime":"0","endTime":"0","summary":"北京时间2025年10月29日23时48分,Biorestorative Therapies, Inc.股票出现异动,股价急速下挫5.45%。截至发稿,该股报1.56美元/股,成交量7.5662万股,换手率0.95%,振幅6.66%。Biorestorative Therapies, Inc.股票所在的生物技术行业中,整体涨幅为0.14%。其相关个股中,Purple Biotech Ltd、Ernexa Therapeutics Inc.、Genenta Science Spa涨幅较大,Purple Biotech Ltd、Ernexa Therapeutics Inc.、Aditxt, Inc.较为活跃,换手率分别为3768.72%、2333.98%、357.42%,振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Ernexa Therapeutics Inc.、Purple Biotech Ltd,振幅分别为132.67%、91.19%、90.91%。Biorestorative Therapies, Inc.公司简介:BioRestorative Therapies Inc 是一家总部位于美国的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251029234852a6d527c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251029234852a6d527c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BRTX","BK4139"],"gpt_icon":0},{"id":"1123009566","title":"BioRestorative获得日本专利批准通知 – 拓展对潜在细胞基替代品的保护,目标为数十亿美元的GLP-1药物市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1123009566","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123009566?lang=zh_cn&edition=full","pubTime":"2025-10-27 19:31","pubTimestamp":1761564698,"startTime":"0","endTime":"0","summary":"BioRestorative获得日本专利批准通知 – 拓展对潜在细胞基替代品的保护,目标为数十亿美元的GLP-1药物市场","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRTX","BK4139"],"gpt_icon":0},{"id":"1124948942","title":"BioRestorative加强商业领导力,任命Crystal Romano为全球商业运营负责人以加速细胞产品组合的增长","url":"https://stock-news.laohu8.com/highlight/detail?id=1124948942","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124948942?lang=zh_cn&edition=full","pubTime":"2025-10-22 21:36","pubTimestamp":1761140177,"startTime":"0","endTime":"0","summary":"BioRestorative加强商业领导力,任命Crystal Romano为全球商业运营负责人,以推动细胞产品组合的增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRTX","BK4139"],"gpt_icon":0},{"id":"2572145105","title":"Biorestorative Therapies, Inc.盘中异动 股价大跌6.90%报1.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572145105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572145105?lang=zh_cn&edition=full","pubTime":"2025-10-01 21:32","pubTimestamp":1759325539,"startTime":"0","endTime":"0","summary":"北京时间2025年10月01日21时32分,Biorestorative Therapies, Inc.股票出现异动,股价大幅下挫6.90%。截至发稿,该股报1.35美元/股,成交量2159股,换手率0.03%,振幅2.45%。Biorestorative Therapies, Inc.股票所在的生物技术行业中,整体涨幅为1.15%。其相关个股中,Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Palisade Bio, Inc.、知临集团涨幅较大,Palisade Bio, Inc.、Scisparc Ltd.、Plus Therapeutics, Inc.较为活跃,换手率分别为117.78%、10.19%、8.31%,振幅较大的相关个股有Palisade Bio, Inc.、Lb Pharmaceuticals Inc、Genprex, Inc.,振幅分别为20.94%、10.01%、7.79%。Biorestorative Therapies, Inc.公司简介:BioRestorative Therapies Inc 是一家总部位于美国的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251001213219a4502d91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251001213219a4502d91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BRTX","BK4139"],"gpt_icon":0},{"id":"2517940515","title":"Biorestorative Therapies, Inc.盘中异动 大幅上涨5.59%报1.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517940515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517940515?lang=zh_cn&edition=full","pubTime":"2025-03-06 01:27","pubTimestamp":1741195676,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日01时27分,Biorestorative Therapies, Inc.股票出现波动,股价大幅上涨5.59%。Biorestorative Therapies, Inc.股票所在的生物技术行业中,整体涨幅为1.22%。其相关个股中,Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nutriband Inc C/Wts 涨幅较大,Silexion Therapeutics Corp、Tc Biopharm Plc、Bioxcel Therapeutics, Inc.较为活跃,换手率分别为935.40%、303.89%、292.29%,振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc.,振幅分别为82.59%、54.27%、47.22%。Biorestorative Therapies, Inc.公司简介:BioRestorative Therapies Inc 是一家总部位于美国的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306012756963b03bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306012756963b03bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BRTX"],"gpt_icon":0},{"id":"2516672095","title":"Biorestorative Therapies, Inc.盘中异动 早盘股价大跌7.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516672095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516672095?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:35","pubTimestamp":1741098903,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时35分,Biorestorative Therapies, Inc.股票出现异动,股价大幅跳水7.28%。Biorestorative Therapies, Inc.股票所在的生物技术行业中,整体涨幅为0.11%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Capricor Therapeutics, Inc.涨幅较大,Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃,换手率分别为1075.00%、1069.41%、423.76%,振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Adma Biologics Inc、Ibio, Inc.,振幅分别为23.30%、12.57%、12.01%。Biorestorative Therapies, Inc.公司简介:BioRestorative Therapies Inc 是一家总部位于美国的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223504963945a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223504963945a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BRTX"],"gpt_icon":0},{"id":"2514373892","title":"Biorestorative Therapies, Inc.盘中异动 早盘股价大跌5.56%报1.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514373892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514373892?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:48","pubTimestamp":1740754100,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时48分,Biorestorative Therapies, Inc.股票出现波动,股价快速下跌5.56%。Biorestorative Therapies, Inc.股票所在的生物技术行业中,整体涨幅为0.22%。其相关个股中,Virpax Pharmaceuticals, Inc.、Tc Biopharm Plc C/Wts 10/02/2028 、Immunitybio, Inc.涨幅较大,Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃,换手率分别为515.28%、351.16%、282.74%,振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Enveric Biosciences, Inc.,振幅分别为45.32%、31.14%、29.25%。Biorestorative Therapies, Inc.公司简介:BioRestorative Therapies Inc 是一家总部位于美国的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822482096341e14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822482096341e14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BRTX","BK4139"],"gpt_icon":0},{"id":"2514023383","title":"Biorestorative Therapies, Inc.盘中异动 早盘股价大跌9.69%报1.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514023383","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514023383?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:40","pubTimestamp":1740667202,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时40分,Biorestorative Therapies, Inc.股票出现异动,股价大幅跳水9.69%。Biorestorative Therapies, Inc.股票所在的生物技术行业中,整体涨幅为0.69%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大,Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃,换手率分别为449.87%、93.40%、75.31%,振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Channel Therapeutics Corporation、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ,振幅分别为33.63%、16.89%、16.72%。Biorestorative Therapies, Inc.公司简介:BioRestorative Therapies Inc 是一家总部位于美国的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227224002989511d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227224002989511d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BRTX"],"gpt_icon":0},{"id":"2514409030","title":"Biorestorative Therapies, Inc.盘中异动涨4.37% 换手率达23.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514409030","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514409030?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:42","pubTimestamp":1740494523,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时42分,Biorestorative Therapies, Inc.股票出现波动,股价急速拉升4.37%。截至发稿,该股报1.67美元/股,成交量162.299万股,换手率23.45%,振幅9.99%。Biorestorative Therapies, Inc.股票所在的生物技术行业中,整体涨幅为0.18%。其相关个股中,Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Moleculin Biotech, Inc.涨幅较大,Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为840.58%、605.20%、522.67%,振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Gt Biopharma, Inc.,振幅分别为100.27%、37.50%、33.50%。Biorestorative Therapies, Inc.公司简介:BioRestorative Therapies Inc 是一家总部位于美国的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224203abdc80cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224203abdc80cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BRTX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biorestorative.com","stockEarnings":[{"period":"1week","weight":-0.1366},{"period":"1month","weight":-0.7896},{"period":"3month","weight":-0.7855},{"period":"6month","weight":-0.8742},{"period":"1year","weight":-0.8788},{"period":"ytd","weight":-0.8031}],"compareEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":-0.0089},{"period":"3month","weight":0.0086},{"period":"6month","weight":0.0686},{"period":"1year","weight":0.1594},{"period":"ytd","weight":0.0108}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Biorestorative医疗公司于1997年6月13日在内华达州注册成立。该公司目前正在开展Disc/Spine计划,初步研究治疗产品被称为BRTX-100。2022年3月,在Disc/Spine Program中发布了一项美国专利。该公司向美国食品药品监督管理局(FDA)提交了一份IND申请,以获得授权开始一项2期临床试验,调查使用BRTX-100治疗退行性椎间盘疾病引起的慢性下背痛。该公司已获得FDA的此类授权,并已开始此类临床试验。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.012358},{"month":2,"riseRate":0.375,"avgChangeRate":-0.140291},{"month":3,"riseRate":0.428571,"avgChangeRate":0.042865},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.075766},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.094493},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.032295},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.123188},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.039767},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.092188},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.096202},{"month":11,"riseRate":0.125,"avgChangeRate":8.440161},{"month":12,"riseRate":0.25,"avgChangeRate":-0.213868}],"exchange":"NASDAQ","name":"BioRestorative Therapies, Inc.","nameEN":"BioRestorative Therapies, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioRestorative Therapies, Inc.(BRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BioRestorative Therapies, Inc.(BRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BioRestorative Therapies, Inc.,BRTX,BioRestorative Therapies, Inc.股票,BioRestorative Therapies, Inc.股票老虎,BioRestorative Therapies, Inc.股票老虎国际,BioRestorative Therapies, Inc.行情,BioRestorative Therapies, Inc.股票行情,BioRestorative Therapies, Inc.股价,BioRestorative Therapies, Inc.股市,BioRestorative Therapies, Inc.股票价格,BioRestorative Therapies, Inc.股票交易,BioRestorative Therapies, Inc.股票购买,BioRestorative Therapies, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioRestorative Therapies, Inc.(BRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BioRestorative Therapies, Inc.(BRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}